Predicting steroid-dependent liver injury with blood test
Part of Digestive system, Immune system & allergy clinical trials.
This study looks at whether a specific blood marker can predict which patients with liver inflammation will need long-term steroid treatment. It may help doctors decide the best treatment for you if you have unexplained liver injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be having a liver biopsy to find out what is causing your liver problem.
- You must give your permission (informed consent) to join the study.
- Your liver disease must be one that doctors consider needing further testing.
- You cannot be taking medications that suppress your immune system (like steroids or other immunosuppressants) right now or right before the biopsy.
- You cannot already have a known liver disease diagnosis (like fatty liver or hepatitis B or D) — the biopsy must be for a new or unclear liver problem.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what factors affect how well the liver responds to treatment in people with autoimmune hepatitis. It may help doctors understand why some people respond better than others and could lead to more personalized care.
This study looks at fats (lipids) in the blood of people with autoimmune hepatitis to find patterns that might help diagnose or monitor the disease. It may lead to better ways to manage the condition.
This study compares patterns of liver inflammation and the liver’s healing ability in people with alcohol-related liver disease, using blood tests and (in most cases) a liver tissue sample. It may help doctors better understand what is happening in the liver and how it may recover.
This study checks whether a special blood test can predict who is at higher risk of graft loss (the transplanted liver not working well) and death after a liver transplant. It may help doctors identify higher-risk patients earlier and tailor follow-up care.
This study measures blood “biomarkers” (signals in blood) to better understand inflammatory diseases, including autoimmune and autoinflammatory conditions. You may be asked to give blood samples now and possibly extra samples if needed for testing.
This study is testing a new way to predict how well steroid treatment will work for people with severe autoimmune hepatitis, a condition where the immune system attacks the liver. If you qualify, the findings may help doctors personalize your care and improve outcomes.
Hear when a new Autoimmune Hepatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.